Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study

BACKGROUND: Thrombotic events are common in critically ill patients with COVID-19 and have been linked with COVID-19- induced hyperinflammatory state. In addition to anticoagulant effects, heparin and its derivatives have various anti-inflammatory and immunomodulatory properties that may affect pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Aljuhani, Ohoud, Korayem, Ghazwa B., Hafiz, Awatif, Alalawi, Mai, Badreldin, Hisham A., Altebainawi, Ali F., Vishwakarma, Ramesh, Alissa, Abdulrahman, Alghamdi, Albandari, Alenazi, Abeer A., Al Enazi, Huda, Alanazi, Shahad, Alhammad, Abdullah, Alghamdi, Jahad, AlFaifi, Mashael, Al Sehli, Faisal A., Aldossari, Maram A., Alhubaishi, Alaa A., Al-Ali, Anfal Y., Al-Dorzi, Hasan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733230/
https://www.ncbi.nlm.nih.gov/pubmed/36482388
http://dx.doi.org/10.1186/s12959-022-00432-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733230/
https://www.ncbi.nlm.nih.gov/pubmed/36482388
http://dx.doi.org/10.1186/s12959-022-00432-9

Ejemplares similares